HealthQuill India
A ransomware group has breached the information security network of India's Sun Pharmaceuticals unit, and there is a possibility that "file systems, business and personal data" might have been compromised.
Drugs Medical Pharma

Ransomware group behind cyberattack: Sun Pharma

A ransomware group has breached the information security network of India's Sun Pharmaceuticals unit, and there is a possibility that "file systems, business and personal.

Read More
The Indian government and the World Bank signed two agreements to support and enhance the development of the health sector in the south Asian nation.
Health Pharma

World Bank loans India $1 billion to aid healthcare sector

The Indian government and the World Bank signed two agreements to support and enhance the development of the health sector in the south.

Read More
India's WiproLab45 unveiled its Decentralized Identity and Credential Exchange (DICE) ID to put the user in control of their medical data, approval to share customer details, and enable citizens to claim government benefits.
Medical Pharma

Wipro unveils ‘tamper-proof’ self-verifiable digital wallet

India's WiproLab45 unveiled its Decentralized Identity and Credential Exchange (DICE) ID to put the user in control of their medical data, approval to.

Read More
blue light filtering not beneficial for eye health
Drugs Pharma

Global Pharma recalls eye drops after FDA contamination warning

India-based Global Pharma Healthcare voluntarily recalled all lots of its artificial tears lubricant eye drops after the USFDA reported possible contamination.

Read More
Max Healthcare, one of India’s largest private hospital chains, reported a 7% rise in profit after tax, on revenue of INR 15.6 billion, as average per occupied bed and international patient revenues jumped.
Drugs Medical Pharma

Max Healthcare profit jumps 7%, to raise INR 42 billion in debt

Max Healthcare, one of India’s largest private hospital chains, reported a 7% rise in profit after tax, on revenue of INR 15.6 billion,.

Read More
Stelis Biopharma, a division of India’s Strides Pharma Science, will become a full-fledged contract development and manufacturing firm and may list “near-term.
Drugs Health Pharma

Stelis Biopharma to be pure play CDMO firm, may list ‘near term’

Stelis Biopharma, a division of India’s Strides Pharma Science, will become a full-fledged contract development and manufacturing firm and may list “near-term.

Read More
Glenmark Pharmaceuticals, an Indian global drug maker with a focus on dermatology, respiratory and oncology areas, forecasts lifting of China's COVID-19 curbs may ease disruptions in the supply chain situation.
Drugs Medical Pharma

China’s lifting of COVID-19 curbs to ease supply chain disruptions: Glenmark

Glenmark Pharmaceuticals, an Indian global drug maker with a focus on dermatology, respiratory and oncology areas, forecasts lifting of China's COVID-19 curbs may.

Read More
The Indian pharmaceutical market is estimated to be worth $130 billion by 2030 from an estimated US$ 41 billion in 2021, the Economic Survey, a government report, stated.
Drugs Pharma

India’s pharma market to be worth $130 billion by 2030

The Indian pharmaceutical market is estimated to be worth $130 billion by 2030 from an estimated US$ 41 billion in 2021, the Economic.

Read More
PathLabs Unifiers, a subsidiary of diagnostic services company Dr. Lal PathLabs, has acquired a 10% stake in one of its business units, APRL PathLabs, in INR 7.5 million in cash.
Drugs Medical Pharma

Indian diagnostic firm Dr. Lal PathLabs acquires 10% of subsidiary

PathLabs Unifiers, a subsidiary of diagnostic services company Dr. Lal PathLabs, has acquired a 10% stake in one of its business units, APRL.

Read More
Bharat Biotech, an Indian maker of vaccines for infectious diseases, has rolled out the world's first nasal Covid-19 drops as a booster dose, according to a company statement.
Drugs Medical Pharma

India’s Bharat Biotech rolls out Covid-19 nasal drop vaccine

Bharat Biotech, an Indian maker of vaccines for infectious diseases, has rolled out the world's first nasal Covid-19 drops as a booster dose,.

Read More